查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1945290

2026年全球止血剂和组织密封胶市场报告

Hemostats And Tissue Sealants Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，止血剂和组织黏合剂市场经历了显着成长，预计将从2025年的43.5亿美元成长到2026年的46.4亿美元，复合年增长率为6.7%。成长要素包括对传统机械止血装置的依赖、合成密封剂供应有限、手术量增加、医院基础设施扩建以及纤维蛋白基密封剂的早期应用。

预计未来几年，止血剂和组织黏合剂市场规模将强劲成长，到2030年将达到59.7亿美元，复合年增长率（CAGR）为6.5%。预测期内的成长可归因于新一代组织黏合剂的研发、微创手术的兴起、心血管和创伤手术的拓展、止血技术研究的增加以及直销和线上分销管道的扩张。预测期内的主要趋势包括：先进止血产品的日益普及、合成和复合密封剂使用量的增加、心血管和创伤手术的拓展、对微创和快速康復手术的关注，以及止血领域研发和学术应用的不断增加。

预计外科手术数量的增加将推动止血剂和组织密封胶市场的扩张。外科手术是指外科医师使用各种技术和器械对病变组织或器官进行诊断、治疗或切除，或恢復身体功能的手术。手术数量的增加主要是由于慢性病盛行率的上升。慢性病通常需要手术介入才能妥善管理和治疗，并预防併发症。止血剂和组织密封胶在有效控制出血和密封组织、最大限度地减少併发症和改善手术效果方面发挥关键作用。例如，2024年6月，总部位于美国的国际美容整形外科学会（ISAPS，一个由获得认证的美容整形外科医生组成的专业协会）报告称，2023年全球外科手术数量增长了5.5%，超过1580万例，非手术治疗数量超过1910万例。这一趋势凸显了外科手术数量的增加如何推动了对止血剂和组织密封胶的需求。

止血和组织密封胶市场的主要企业正优先开发创新产品，例如即用型可吸收胶原蛋白贴片，以提高外科手术的有效性和效率。这些基于胶原蛋白的止血剂采用生物活性可吸收材料製成，无需任何准备，即可即时使用，有效密封组织并止血。 2025年4月，总部位于美国的医疗公司百特国际在奥地利举办的研讨会上推出了「Hemopatch 密封止血贴」。这款新产品无需开放性手术即可使用，无需冷藏或额外准备。 Hemopatch 具有强大的黏合性、较长的保质期和快速止血效果，可简化术中出血和渗漏的处理，从而提高手术精度，并加快患者在各种专科领域的康復。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球止血剂及组织密封胶市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 工业4.0和智慧製造
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 自主系统、机器人与智慧运输
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 先进止血产品的应用日益广泛
    • 合成和复合密封剂的使用日益增多
    • 扩大心血管和创伤外科手术
    • 专注于微创手术，以加快恢復速度。
    • 拓展止血领域的研究与学术应用范围

第五章 终端用户产业市场分析

  • 医院
  • 门诊手术中心（ASC）
  • 专科诊所
  • 研究和学术机构
  • 心血管与创伤中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球止血剂和组织密封胶市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球止血剂及组织密封胶市场规模、比较及成长率分析
  • 全球止血剂和组织密封胶市场表现：规模和成长，2020-2025年
  • 全球止血剂和组织密封胶市场预测：规模和成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依产品类型
  • 局部止血剂、黏合剂和组织密封胶、纤维蛋白胶、其他产品类型
  • 按成分
  • 生物来源的、合成的和复杂的
  • 透过分销管道
  • 直销、经销商、线上销售
  • 透过使用
  • 外科手术、创伤、心血管、一般外科及其他应用
  • 最终用户
  • 医院、门诊手术中心、专科诊所、研究及学术机构
  • 按类型细分：局部止血剂
  • 机械止血剂、活性止血剂、流动性止血剂及混合型止血剂
  • 按类型细分：黏合剂和组织密封胶
  • 合成组织黏合剂、生物组织黏合剂、氰基丙烯酸黏合剂
  • 按类型细分：纤维蛋白胶
  • 液态纤维蛋白胶，贴片式纤维蛋白胶
  • 按类型细分：其他产品类型
  • 明胶基止血剂、胶原蛋白基止血剂、氧化再生纤维素基止血剂

第十章 区域与国家分析

  • 全球止血剂及组织密封胶市场：区域分析、预测及展望（2020-2025年、2025-2030年、2035年）。
  • 全球止血剂和组织密封胶市场：按国家/地区、绩效和预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 止血剂和组织密封胶市场：竞争格局和市场份额，2024 年
  • 止血剂与组织密封胶市场：公司估值矩阵
  • 止血剂和组织密封胶市场：公司概况
    • Johnson & Johnson
    • Medtronic plc
    • Becton, Dickinson and Company（BD）
    • Stryker Corporation
    • Baxter International Inc.

第37章：其他领先和创新企业

  • Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年止血剂和组织密封胶市场：提供新机会的国家
  • 2030年止血剂与组织密封胶市场：充满新机会的细分市场
  • 2030年止血剂和组织密封胶市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MHTSI01_G26Q1

Hemostats and tissue sealants are products utilized during surgical procedures to manage bleeding (hemostasis) and seal tissues, thereby preventing the leakage of fluids like blood or air. Hemostats function by either encouraging clot formation or physically clamping blood vessels to halt bleeding, while tissue sealants are used to close wounds or surgical cuts, supporting quicker healing and lowering the likelihood of complications.

The primary categories of hemostats and tissue sealants include topical hemostats, adhesives and tissue sealants, fibrin sealants, and others. Topical hemostats are substances or materials directly applied to bleeding areas to control bleeding during surgeries or traumatic injuries. These are formulated from biological-based, synthetic-based, or combined materials, and are distributed through various channels such as direct sales, distributors, and online platforms. Their applications span across surgical procedures, trauma care, cardiovascular and general surgeries, among others, and they serve multiple end users including hospitals, ambulatory surgical centers (ASCs), specialty clinics, and academic and research institutions.

Tariffs are impacting the hemostats and tissue sealants market by increasing costs of imported biological and synthetic raw materials used in product manufacturing. Segments such as fibrin sealants and combination hemostats are most impacted, with Asia-Pacific regions like China and India facing significant import duties. This has led to higher production costs and supply chain delays. Positively, tariffs have driven local manufacturing initiatives, encouraged material innovation, and promoted investment in domestic production capabilities.

The hemostats and tissue sealants market research report is one of a series of new reports from The Business Research Company that provides hemostats and tissue sealants market statistics, including hemostats and tissue sealants industry global market size, regional shares, competitors with a hemostats and tissue sealants market share, detailed hemostats and tissue sealants market segments, market trends and opportunities, and any further data you may need to thrive in the hemostats and tissue sealants industry. This hemostats and tissue sealants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostats and tissue sealants market size has grown strongly in recent years. It will grow from $4.35 billion in 2025 to $4.64 billion in 2026 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to reliance on traditional mechanical hemostats, limited availability of synthetic sealants, increasing surgical procedures, growing hospital infrastructure, early adoption of fibrin-based sealants.

The hemostats and tissue sealants market size is expected to see strong growth in the next few years. It will grow to $5.97 billion in 2030 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to development of next-generation tissue adhesives, rising minimally invasive surgeries, growing cardiovascular and trauma surgeries, increased research in hemostasis technologies, expansion of direct and online distribution channels. Major trends in the forecast period include rising adoption of advanced hemostatic products, increased use of synthetic and combination sealants, expansion of cardiovascular and trauma surgeries, focus on minimally invasive and faster recovery procedures, growing research and academic applications in hemostasis.

The growing number of surgical procedures is expected to drive the expansion of the hemostats and tissue sealants market. Surgical procedures involve manual and instrumental techniques performed by surgeons to diagnose, treat, or remove diseased tissues or organs, or to restore bodily functions. The increase in these procedures is largely attributed to the rising prevalence of chronic diseases, which frequently require surgical intervention for proper management, treatment, or to prevent complications. Hemostats and tissue sealants play a crucial role in these procedures by effectively controlling bleeding and sealing tissues, thereby minimizing complications and enhancing surgical outcomes. For example, in June 2024, the International Society of Aesthetic Plastic Surgery (ISAPS), a U.S.-based professional organization for board-certified aesthetic plastic surgeons, reported a 5.5% increase in surgical procedures in 2023, with over 15.8 million surgeries and 19.1 million non-surgical procedures conducted worldwide. This trend underscores how the increasing number of surgical procedures is fueling the demand for hemostats and tissue sealants.

Leading companies in the hemostats and tissue sealants market are prioritizing the development of innovative products, such as ready-to-use absorbable collagen pads, to enhance the effectiveness and efficiency of surgical care. These collagen-based hemostats are designed using bioactive, resorbable materials that require no preparation, offering immediate application for effective tissue sealing and hemostasis. In April 2025, Baxter International Inc., a U.S.-based healthcare company, introduced the Hemopatch Sealing Hemostat at a symposium in Austria. This new product is designed for room temperature storage and offers the convenience of being ready-to-use without the need for pre-warming. It is suitable for both open and minimally invasive surgeries and eliminates the need for refrigeration or additional preparation. The Hemopatch's strong adhesive capabilities, extended shelf life, and rapid hemostatic response enable more efficient bleeding and leakage control during surgery, contributing to improved surgical precision and better patient recovery outcomes across various specialties.

In March 2024, Advanced Medical Solutions Group PLC, a UK-based medical technology company, acquired Peters Surgical SAS for $154.6 million. This acquisition is aimed at expanding Advanced Medical Solutions' surgical product portfolio, reinforcing its footprint in key European markets, and enhancing its position in the global wound care and closure technologies sector. Peters Surgical SAS, based in France, specializes in producing medical devices and instruments focused on hemostats and tissue sealants.

Major companies operating in the hemostats and tissue sealants market are Johnson & Johnson, Medtronic plc, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

North America was the largest region in the hemostats and tissue sealants market in 2025. The regions covered in the hemostats and tissue sealants market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the hemostats and tissue sealants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hemostats and tissue sealants market consists of sales of gelatin-based hemostats, fibrin sealants, oxidized regenerated cellulose, thrombin-based hemostats, and cyanoacrylate-based tissue adhesives. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostats And Tissue Sealants Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses hemostats and tissue sealants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostats and tissue sealants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemostats and tissue sealants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Topical Hemostats; Adhesives And Tissue Sealants; Fibrin Sealants; Other Product Types
  • 2) By Composition: Biological Based; Synthetic Based; Combination
  • 3) By Distribution Channel: Direct Sales; Distributors; Online Sales
  • 4) By Application: Surgical Procedures; Trauma Cases; Cardiovascular Surgery; General Surgery; Other Applications
  • 5) By End-Users: Hospitals; Ambulatory Surgical Centers (ASCs); Specialized Clinics; Research And Academic Institutes
  • Subsegments:
  • 1) By Topical Hemostats: Mechanical Hemostats; Active Hemostats; Flowable Hemostats; Combination Hemostats
  • 2) By Adhesives And Tissue Sealants: Synthetic Tissue Adhesives; Biological Tissue Adhesives; Cyanoacrylate-Based Adhesives
  • 3) By Fibrin Sealants: Liquid Fibrin Sealants; Patch-Based Fibrin Sealants
  • 4) By Other Product Types: Gelatin-Based Hemostats; Collagen-Based Hemostats; Oxidized Regenerated Cellulose-Based Hemostats
  • Companies Mentioned: Johnson & Johnson; Medtronic plc; Becton Dickinson and Company (BD); Stryker Corporation; Baxter International Inc.; Meril Life Sciences Pvt. Ltd.; Teleflex Incorporated; Integra LifeSciences Holdings Corporation; Corza Medical Inc.; Artivion Inc.; Ethicon Inc.; Advanced Medical Solutions Group plc; Marine Polymer Technologies Inc.; Samyang Holdings Corporation; 3-D Matrix Medical Technology Co Ltd.; GELITA AG; BioCer Entwicklungs-GmbH; AEGIS Lifesciences Pvt. Ltd.; Betatech Medical Ltd.; Cohera Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Hemostats And Tissue Sealants Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Hemostats And Tissue Sealants Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Hemostats And Tissue Sealants Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Hemostats And Tissue Sealants Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Industry 4.0 & Intelligent Manufacturing
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Autonomous Systems, Robotics & Smart Mobility
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Advanced Hemostatic Products
    • 4.2.2 Increased Use Of Synthetic And Combination Sealants
    • 4.2.3 Expansion Of Cardiovascular And Trauma Surgeries
    • 4.2.4 Focus On Minimally Invasive And Faster Recovery Procedures
    • 4.2.5 Growing Research And Academic Applications In Hemostasis

5. Hemostats And Tissue Sealants Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers (Ascs)
  • 5.3 Specialized Clinics
  • 5.4 Research And Academic Institutes
  • 5.5 Cardiovascular And Trauma Centers

6. Hemostats And Tissue Sealants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Hemostats And Tissue Sealants Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Hemostats And Tissue Sealants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Hemostats And Tissue Sealants Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Hemostats And Tissue Sealants Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Hemostats And Tissue Sealants Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Hemostats And Tissue Sealants Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Hemostats And Tissue Sealants Market Segmentation

  • 9.1. Global Hemostats And Tissue Sealants Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Topical Hemostats, Adhesives And Tissue Sealants, Fibrin Sealants, Other Product Types
  • 9.2. Global Hemostats And Tissue Sealants Market, Segmentation By Composition, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biological Based, Synthetic Based, Combination
  • 9.3. Global Hemostats And Tissue Sealants Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Sales, Distributors, Online Sales
  • 9.4. Global Hemostats And Tissue Sealants Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Surgical Procedures, Trauma Cases, Cardiovascular Surgery, General Surgery, Other Applications
  • 9.5. Global Hemostats And Tissue Sealants Market, Segmentation By End-Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers (ASCs), Specialized Clinics, Research And Academic Institutes
  • 9.6. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Topical Hemostats, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mechanical Hemostats, Active Hemostats, Flowable Hemostats, Combination Hemostats
  • 9.7. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Adhesives And Tissue Sealants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Synthetic Tissue Adhesives, Biological Tissue Adhesives, Cyanoacrylate-Based Adhesives
  • 9.8. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Fibrin Sealants, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liquid Fibrin Sealants, Patch-Based Fibrin Sealants
  • 9.9. Global Hemostats And Tissue Sealants Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats

10. Hemostats And Tissue Sealants Market Regional And Country Analysis

  • 10.1. Global Hemostats And Tissue Sealants Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Hemostats And Tissue Sealants Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Hemostats And Tissue Sealants Market

  • 11.1. Asia-Pacific Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Hemostats And Tissue Sealants Market

  • 12.1. China Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Hemostats And Tissue Sealants Market

  • 13.1. India Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Hemostats And Tissue Sealants Market

  • 14.1. Japan Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Hemostats And Tissue Sealants Market

  • 15.1. Australia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Hemostats And Tissue Sealants Market

  • 16.1. Indonesia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Hemostats And Tissue Sealants Market

  • 17.1. South Korea Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Hemostats And Tissue Sealants Market

  • 18.1. Taiwan Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Hemostats And Tissue Sealants Market

  • 19.1. South East Asia Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Hemostats And Tissue Sealants Market

  • 20.1. Western Europe Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Hemostats And Tissue Sealants Market

  • 21.1. UK Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Hemostats And Tissue Sealants Market

  • 22.1. Germany Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Hemostats And Tissue Sealants Market

  • 23.1. France Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Hemostats And Tissue Sealants Market

  • 24.1. Italy Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Hemostats And Tissue Sealants Market

  • 25.1. Spain Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Hemostats And Tissue Sealants Market

  • 26.1. Eastern Europe Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Hemostats And Tissue Sealants Market

  • 27.1. Russia Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Hemostats And Tissue Sealants Market

  • 28.1. North America Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Hemostats And Tissue Sealants Market

  • 29.1. USA Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Hemostats And Tissue Sealants Market

  • 30.1. Canada Hemostats And Tissue Sealants Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Hemostats And Tissue Sealants Market

  • 31.1. South America Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Hemostats And Tissue Sealants Market

  • 32.1. Brazil Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Hemostats And Tissue Sealants Market

  • 33.1. Middle East Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Hemostats And Tissue Sealants Market

  • 34.1. Africa Hemostats And Tissue Sealants Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Hemostats And Tissue Sealants Market, Segmentation By Product Type, Segmentation By Composition, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Hemostats And Tissue Sealants Market Regulatory and Investment Landscape

36. Hemostats And Tissue Sealants Market Competitive Landscape And Company Profiles

  • 36.1. Hemostats And Tissue Sealants Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Hemostats And Tissue Sealants Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Hemostats And Tissue Sealants Market Company Profiles
    • 36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Becton, Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Hemostats And Tissue Sealants Market Other Major And Innovative Companies

  • Meril Life Sciences Pvt. Ltd., Teleflex Incorporated, Integra LifeSciences Holdings Corporation, Corza Medical Inc., Artivion Inc., Ethicon Inc., Advanced Medical Solutions Group plc, Marine Polymer Technologies Inc., Samyang Holdings Corporation, 3-D Matrix Medical Technology Co Ltd., GELITA AG, BioCer Entwicklungs-GmbH, AEGIS Lifesciences Pvt. Ltd., Betatech Medical Ltd., Cohera Medical Inc.

38. Global Hemostats And Tissue Sealants Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Hemostats And Tissue Sealants Market

40. Hemostats And Tissue Sealants Market High Potential Countries, Segments and Strategies

  • 40.1 Hemostats And Tissue Sealants Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Hemostats And Tissue Sealants Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Hemostats And Tissue Sealants Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer